Page last updated: 2024-08-23

alovudine and laq824

alovudine has been researched along with laq824 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aboagye, EO; Alao, JP; Atadja, P; Da Costa, M; He, Q; Lam, EW; Latigo, JR; Leyton, J; Perumal, M; Pillai, R; Stavropoulou, AV; Vigushin, DM; Workman, P	1

Other Studies

1 other study(ies) available for alovudine and laq824

Article	Year
In vivo biological activity of the histone deacetylase inhibitor LAQ824 is detectable with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography. Cancer research, 2006, Aug-01, Volume: 66, Issue:15 Topics: Animals; Cell Cycle; Cell Growth Processes; Colonic Neoplasms; Dideoxynucleosides; Drug Interactions; Female; HCT116 Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Radiopharmaceuticals; Random Allocation; RNA, Messenger; Thymidine Kinase; Xenograft Model Antitumor Assays	2006

Article

Year

In vivo biological activity of the histone deacetylase inhibitor LAQ824 is detectable with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography.

Cancer research, 2006, Aug-01, Volume: 66, Issue:15

Topics: Animals; Cell Cycle; Cell Growth Processes; Colonic Neoplasms; Dideoxynucleosides; Drug Interactions; Female; HCT116 Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Radiopharmaceuticals; Random Allocation; RNA, Messenger; Thymidine Kinase; Xenograft Model Antitumor Assays

2006